Table of Contents
Perspectives
| Toward a "tailored" era for basic research and clinical therapy of lung cancer-a report of the 12th World Conference on Lung Cancer | |
| Qinghua Zhou, Zhihao Wu | 1-3 |
| Advance of second-line chemotherapy in advanced non-small cell lung cancer | |
| Li Zhang | 4-9 |
| Progress of clinical research in "tailor" chemotherapy for non-small-cell lung cancer | |
| Gang Cheng | 10-13 |
| Advances of maintenance chemotherapy on advanced non-small cell lung cancer | |
| Xinghao Ai, Shun Lu | 14-16 |
| Advances of imaging diagnostics for lung cancer | |
| Guozhen Zhang | 17-20 |
| Molecular diagnostics and molecular prognosis in lung cancer | |
| Caicun Zhou | 21-24 |
| Advances on epidemiology of lung cancer and tobacco control | |
| Chengping Hu | 25-28 |
| Approaches on genetics and molecular biology of lung cancer--a review on the 12th World Conference on Lung Cancer | |
| Ke Xu | 29-33 |
| Molecular diagnostics and molecular staging of lung cancer | |
| Zhihao Wu, Qinghua Zhou | 34-39 |
| Advances on lung cancer metastasis | |
| Hongyu Liu, Jun Chen | 40-42 |
| Progress in research on lung cancer vaccine | |
| Zhen Huang, Jie Wang | 43-45 |
Basic Research
| Construction of FasL siRNA expression vector and its expression in lung cancer cell line A549 | |
| Haidong Wang, Yaoguang Jiang, Yidan Lin, Ruwen Wang, Bo Deng | 46-50 |
| The morphous analyses of three different characteristics cells growing in soft agar | |
| Fangli Liu, Yang Yu, Songbin Fu | 51-54 |
| Establishment and biological characteristics of a multi-drug resistant cell line A549/Gem | |
| Weixia Wang, Xiaoqing Liu, Guangxian Liu, Li Lin, Xiaoling Zheng, Yunfeng Zhu, Xiaobing Li | 55-61 |
Clinical Research
| Expressions of Frat and beta-catenin in lung cancer and their clinicopathological correlations | |
| Lan Luan, Yong Zhang, Ning Guo, Enhua Wang | 62-66 |
| Expression of ezrin in human lung carcinoma and its clinicopathologic significance | |
| Lan Lan, Tieying Sun, Dongge Liu, Jianxin Pang, Li Yang, Chunzheng Yang, Dongsheng Xiong | 67-73 |
| Correlation between the quantifiable parameters of blood flow pattern derived with dynamic CT in maliagnant solitary pulmonary nodules and tumor size | |
| Shenjiang Li, Xiangsheng Xiao, Shiyuan Liu, Huimin Li, Chengzhou Li, Chenshi Zhang | 74-78 |
| Concurrent chemoradiotherapy with low-dose weekly docetaxel followed by consolidation chemotherapy with docetaxel and cisplatin in the treatment of stage III non-small cell lung cancer | |
| Xiaohong Liu, Hui Chen, Tianlin Xiao, Yiqiang Jin, Huaiyun Chen | 79-84 |
| Expression of RhoE in lung and breast cancer and its clinical significance | |
| Yajie Zhu, Feng Xu, Jitao Zhou, Surui Liu, Juan Huang, Deyun Luo, Meng Qiu, Boquan Jin, Feng Bi | 85-89 |
| Expression and clinical significance of caspase -3, survivin and k-ras in non-small cell lung cancer | |
| Chenghui Li, Bing Hu, Xiaoqiu Wang, Chushu Ji, Yifu He | 90-96 |
| The value of serum tumor marker CA125 and CEA in the diagonosis of non-small cell lung cancer | |
| Haiyan Wang, Zhengxue Zhu, Yan Xiao, Nan Ma, Hongmei Li, Zhongguang Wen | 97-100 |
| Analysis of prognostic factors in 352 lung cancer patients with brain metastases | |
| Hao Bai, Baohui Han | 101-106 |
| Preliminary investigation on expression of Bmi-1 in non-small-cellular lung cancer | |
| Zhonghua Hu, Yide Hu, Yong Zhu | 107-109 |
| A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer | |
| Shucai Zhang, Jinghui Wang, Qunhui Wang, Xinjie Yang, Fanbin Hu, Xi Li, Yanfei Gu, Haiyong Wang | 110-114 |
| The expression and significance of indoleamine -2,3 -dioxygenase in non-small cell lung cancer cell | |
| Qichao Xie, Lingli Wang, Bo Zhu, Yali Wang, jianteng Gu, Zhengtang Chen | 115-119 |
| Effects of MVP regimen on operation and cancer tisswes of Lung Cancer patients | |
| Min Zheng, Gang Chen, Zhengping Ding, Yunzhong Zhou | 120-125 |
| Expression of ER and AR in lung cancer | |
| Ming Yan, Xiaobing Chen, Shuling Wang, Yin Li | 126-129 |
| The relationship between genetic polymorphism of GSTM1 and the outcome of chemotherapy in Chinese patients with primary lung cancer | |
| Weiying Li, Yanfei Gu, Baitang Lai, Hui Wang | 130-136 |
| Clinic outcome of gefitinib in sixty-nine elderly patients with lung adenocarcinoma | |
| Yan Wang, Xiangru Zhang, Bin Wang, Ziping Wang, Datong Chu, Yan Sun | 137-141 |
Clinical Experience
| Clinical experiences | |
| Feng Shao et al | 142-146 |
Minireview
| Chinese review | |
| Yaping Xu et al | 147-153 |
Announcements
| Instructions to authors | |
| Editorial board Chinese Journal of Lung Cancer | 154-156 |
